These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21518928)

  • 1. NKG2D receptor regulates human effector T-cell cytokine production.
    Barber A; Sentman CL
    Blood; 2011 Jun; 117(24):6571-81. PubMed ID: 21518928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
    Whitman E; Barber A
    Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
    Rajasekaran K; Xiong V; Fong L; Gorski J; Malarkannan S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.
    Cerboni C; Ardolino M; Santoni A; Zingoni A
    Blood; 2009 Mar; 113(13):2955-64. PubMed ID: 19124832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.
    Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
    J Leukoc Biol; 2014 Mar; 95(3):487-95. PubMed ID: 24168855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D stimulation of CD8
    Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
    Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.
    Talebian L; Fischer DA; Wu J; Channon JY; Sentman CL; Ernstoff MS; Meehan KR
    Transfusion; 2014 Jun; 54(6):1515-21. PubMed ID: 24446786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D is a costimulatory receptor for human naive CD8+ T cells.
    Maasho K; Opoku-Anane J; Marusina AI; Coligan JE; Borrego F
    J Immunol; 2005 Apr; 174(8):4480-4. PubMed ID: 15814668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of NKG2D expression by IL-4 in memory CD8 T cells.
    Ventre E; Brinza L; Schicklin S; Mafille J; Coupet CA; Marçais A; Djebali S; Jubin V; Walzer T; Marvel J
    J Immunol; 2012 Oct; 189(7):3480-9. PubMed ID: 22942430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 Signals through the TCR To Support CD8 Innate Immune Responses.
    Goplen NP; Saxena V; Knudson KM; Schrum AG; Gil D; Daniels MA; Zamoyska R; Teixeiro E
    J Immunol; 2016 Sep; 197(6):2434-43. PubMed ID: 27521342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
    Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
    Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo.
    Jacquemin C; Martins C; Lucchese F; Thiolat D; Taieb A; Seneschal J; Boniface K
    J Invest Dermatol; 2020 Jun; 140(6):1143-1153.e5. PubMed ID: 31877315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells.
    Fernández-Sánchez A; Baragaño Raneros A; Carvajal Palao R; Sanz AB; Ortiz A; Ortega F; Suárez-Álvarez B; López-Larrea C
    Epigenetics; 2013 Jan; 8(1):66-78. PubMed ID: 23235109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant NKG2D expression with IL-17 production of CD4+ T subsets in patients with type 2 diabetes.
    Phoksawat W; Jumnainsong A; Leelayuwat N; Leelayuwat C
    Immunobiology; 2017 Oct; 222(10):944-951. PubMed ID: 27168217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
    Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
    Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKG2D induces Mcl-1 expression and mediates survival of CD8 memory T cell precursors via phosphatidylinositol 3-kinase.
    Wensveen FM; Lenartic M; Jelencic V; Lemmermann NA; ten Brinke A; Jonjic S; Polic B
    J Immunol; 2013 Aug; 191(3):1307-15. PubMed ID: 23804716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.
    Markiewicz MA; Carayannopoulos LN; Naidenko OV; Matsui K; Burack WR; Wise EL; Fremont DH; Allen PM; Yokoyama WM; Colonna M; Shaw AS
    J Immunol; 2005 Sep; 175(5):2825-33. PubMed ID: 16116168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.